Nathan Comeaux

1.2k total citations · 1 hit paper
9 papers, 559 citations indexed

About

Nathan Comeaux is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nathan Comeaux has authored 9 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Nathan Comeaux's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Nathan Comeaux is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Nathan Comeaux collaborates with scholars based in United States, China and Netherlands. Nathan Comeaux's co-authors include Joe Y. Chang, James W. Welsh, Vivek Verma, Dawei Chen, George R. Simon, Steven H. Lin, John V. Heymach, Ferdinandos Skoulidis, Patricia M. de Groot and Paul Baas and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Nathan Comeaux

8 papers receiving 553 citations

Hit Papers

Pembrolizumab with or without radiotherapy for metastatic... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Comeaux United States 4 444 308 134 76 62 9 559
Jeffrey M. Lemons United States 5 408 0.9× 211 0.7× 157 1.2× 79 1.0× 83 1.3× 8 523
Catherine Wadsworth United States 10 434 1.0× 411 1.3× 74 0.6× 50 0.7× 60 1.0× 18 554
Jahan Aghalar United States 5 269 0.6× 133 0.4× 98 0.7× 66 0.9× 25 0.4× 9 355
Jihane Boustani France 11 155 0.3× 158 0.5× 49 0.4× 139 1.8× 71 1.1× 31 346
Jackie Hernandez United States 5 201 0.5× 101 0.3× 185 1.4× 38 0.5× 33 0.5× 5 365
Oyeon Cho South Korea 12 202 0.5× 96 0.3× 40 0.3× 107 1.4× 53 0.9× 28 378
Chi‐Chung Tong China 13 271 0.6× 136 0.4× 35 0.3× 230 3.0× 55 0.9× 31 590
Thomas Dannenberg Germany 5 178 0.4× 312 1.0× 142 1.1× 76 1.0× 31 0.5× 5 473
Catherine Dubos‐Arvis France 8 310 0.7× 348 1.1× 27 0.2× 36 0.5× 104 1.7× 11 476
Stefano Cappio Italy 7 188 0.4× 137 0.4× 30 0.2× 77 1.0× 40 0.6× 12 310

Countries citing papers authored by Nathan Comeaux

Since Specialization
Citations

This map shows the geographic impact of Nathan Comeaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Comeaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Comeaux more than expected).

Fields of papers citing papers by Nathan Comeaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Comeaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Comeaux. The network helps show where Nathan Comeaux may publish in the future.

Co-authorship network of co-authors of Nathan Comeaux

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Comeaux. A scholar is included among the top collaborators of Nathan Comeaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Comeaux. Nathan Comeaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Chang, Joe Y., Girish S. Shroff, Nathan Comeaux, et al.. (2024). Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies. Journal for ImmunoTherapy of Cancer. 12(10). e009975–e009975. 2 indexed citations
3.
He, Kewen, David S. Hong, Chad Tang, et al.. (2023). Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease. Radiotherapy and Oncology. 183. 109618–109618. 3 indexed citations
4.
Sezen, Duygu, Vivek Verma, Kewen He, et al.. (2021). Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease. Seminars in Radiation Oncology. 31(3). 217–226. 4 indexed citations
5.
He, Kewen, Roshal R. Patel, Joe Y. Chang, et al.. (2021). Phase II Trial of High-Dose Radiotherapy vs. Low-Dose Radiation, Demonstrating Low-Dose Mediated Immune-Cell Infiltration. International Journal of Radiation Oncology*Biology*Physics. 111(3). S118–S118. 3 indexed citations
6.
Theelen, Willemijn S.M.E., Dawei Chen, Vivek Verma, et al.. (2020). Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. The Lancet Respiratory Medicine. 9(5). 467–475. 353 indexed citations breakdown →
7.
Welsh, James W., Dawei Chen, Paul Baas, et al.. (2020). Radiotherapy to augment pembrolizumab responses and outcomes in metastatic non-small cell lung cancer: Pooled analysis of two randomized trials.. Journal of Clinical Oncology. 38(15_suppl). 9548–9548. 9 indexed citations
8.
Welsh, James W., Hari Menon, Dawei Chen, et al.. (2020). Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial. Journal for ImmunoTherapy of Cancer. 8(2). e001001–e001001. 182 indexed citations
9.
Patel, Roshal R., Cheng Guo, David S. Hong, et al.. (2020). Abscopal Response Rates after Salvage Radiation in Patients with Progressive Disease on Immunotherapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). e120–e121. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026